To report the acute toxicity of a hypofractionated regimen of intensity-modulated radiotherapy with simultaneous integrated boost (SIB-IMRT) to the pelvic nodes and the prostatic bed after radical prostatectomy.
Massaccesi, M., Cilla, S., Deodato, F., Digesù, C., Macchia, G., Caravatta, L., Ippolito, E., Picardi, V., Ferro, M., Mignogna, S., Mattiucci, G. C., Valentini, V., Piermattei, A., Morganti, A. G., Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial, <<ANTICANCER RESEARCH>>, 2013; 33 (6): 2785-2789 [http://hdl.handle.net/10807/52305]
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial
Massaccesi, Mariangela;Cilla, Savino;Deodato, Francesco;Macchia, Gabriella;Caravatta, Luciana;Ippolito, Edy;Picardi, Vincenzo;Ferro, Milena;Mignogna, Samantha;Mattiucci, Gian Carlo;Valentini, Vincenzo;Piermattei, Angelo;Morganti, Alessio Giuseppe
2013
Abstract
To report the acute toxicity of a hypofractionated regimen of intensity-modulated radiotherapy with simultaneous integrated boost (SIB-IMRT) to the pelvic nodes and the prostatic bed after radical prostatectomy.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
